RVL Pharmaceuticals PLC (FRA:O1P)
€ 0.003 0 (0%) Market Cap: 1.65 Mil Enterprise Value: 38.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

RVL Pharmaceuticals PLC at Barclays Global Healthcare Conference Transcript

Mar 16, 2022 / 03:15PM GMT
Release Date Price: €1.47 (-0.68%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. My name is Balaji Prasad. I lead the specialty pharmaceuticals coverage for Barclays. And continuing on the spectrum on track, our next company is RVL Pharmaceuticals. And we have the management team, including Brian Markison, the CEO and Andy Einhorn, the CFO. Brian and Andy, thank you for taking your time to be here today.

Brian A. Markison
RVL Pharmaceuticals plc - Chairman, President & CEO

Yes. Thanks for having us.

Andrew J. Einhorn
RVL Pharmaceuticals plc - CFO

Certainly.

Brian A. Markison
RVL Pharmaceuticals plc - Chairman, President & CEO

In sunny Miami today.

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Today -- it's sunny today.

Brian A. Markison
RVL Pharmaceuticals plc - Chairman, President & CEO

Being indoors.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot